Fosamax Tagged Articles
Fosamax maker ordered to pay $285,000 to woman who developed severe jawbone disease
Merck, makers of the osteoporosis drug Fosamax, was ordered to pay $285,000 to a woman who claimed the drug caused her to develop osteonecrosis of the jaw (ONJ) after dental surgery and that the company did not adequately warn about
FDA panel says not enough data to limit osteoporosis drug use
A federal advisory panel said Sept. 9 that it does not have enough data to make recommendations about whether a class of drugs used to treat osteoporosis should not be used long-term. The panel was convened by the Food and Drug
FDA warns of unusual thigh fracture from use of osteoporosis drugs
Widely used osteoporosis drugs designed to prevent bones from breaking may increase the risk of a rare type of thigh fracture, according to the Food and Drug Administration (FDA). The agency notified consumers and health care workers that all bisphosphonates will
FDA review shows no link between bone treatment and thigh fractures
The Food and Drug Administration (FDA) says data from an ongoing safety review of oral bisphosphonates, such as Fosamax, prescribed for the treatment of bone loss, do not appear to be related to an increased risk of thigh fractures. However,
Beasley Allen attorney files lawsuit against maker of Fosamax
Three lawsuits against the makers of Fosamax, a popular medication to prevent bone loss, are slated to go to trial, including one filed in Alabama state court by Beasley Allen attorney W. Chad Cook. The lawsuits are among the nearly
Merck paid publisher to print positive stories about Vioxx, Fosamax
A science and health publisher says years ago it published what appeared to be medical journals for a group of Australian doctors that heavily favored Merck and Co.’s drugs Fosamax and Vioxx. The journals didn’t list who paid for the
Doctor warns against bone density-building drugs
A West Liberty, Iowa, doctor is urging members of his hometown to follow a good diet and do weight-bearing exercise in lieu of taking medications to remedy ailments such as low bone density. Dr. Carl Gillman with West Liberty Chiropractic
Study suggests higher risk of ONJ with Fosamax than previously reported
It seemed suspicious to the team of dentists at the University of Southern California (USC), the fact that so many patients treated at the university dental clinic were being diagnosed with osteonecrosis of the jaw, or ONJ. So dentists there
Osteoporosis treatment has serious risks; consider natural therapy
Osteoprosis poses a serious health risk for women. According to Natural News, women have a higher risk of dying from the bone condition than from breast cancer. But the treatment may be just as dangerous. Fosamax is in a class
